StockWatch
·
HomeLiveReports

Symbiotec Pharmalab Ltd

BSE: 544889

OverviewP/LShare Hold
values in crores
PeriodQ1 FY27
INCOME
Revenue210.84
Other Income19.55
Total Income230.39
EXPENSES
Expenditure167.37
Tax16.01
PROFIT
PBT63.02
Net Profit47.01
KEY METRICS
OPM %28.10%
NPM %20.40%
EPS7.49

Corporate Events

Board MeetingSYMBIOTEC
2026
21Sep

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗